(Circulation. 2004;109:2959-2964.)
© 2004 American Heart Association, Inc.
Clinician Updates |
From the Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Ill (M.G.); the Division of Cardiology, University of North Carolina, Chapel Hill, NC (K.F.A.); and the Division of Cardiology, Boston University, Boston, Mass (W.S.C.).
Correspondence to Mihai Gheorghiade, MD, Northwestern University Feinberg School of Medicine, Galter 10-240, 201 East Huron St, Chicago, IL 60611-2908. E-mail m-gheorghiade@northwestern.edu
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
"After all, in spite of opinion, prejudice or error, time will fix the real value upon this discovery." Sir William Withering, Birmingham, July 1, 1785
Case 1: A 45-year-old man in sinus rhythm, with an ejection fraction of 20%, normal coronaries, and normal renal function is receiving captopril 50 mg 3 times daily, carvedilol 25 mg and furosemide 40 mg twice daily, and spironolactone 25 mg daily. Despite these therapies, he continues to complain of dyspnea with minimal exertion. There are jugular venous distention, rales, and ankle edema. Oral digoxin, 0.125 mg daily, is added. After 3 weeks of maintenance therapy with digoxin, the patient feels better.
Case 2: A 70-year asymptomatic woman in sinus rhythm, with coronary artery disease and ejection fraction of 35% is receiving once a day enalapril 10 mg, metoprolol succinate 200 mg, digoxin 0.125 mg, and furosemide 20 mg. There are no signs of heart failure. Six months after digoxin discontinuation she continues to remain asymptomatic.
Historical Perspectives
As far back as the ancient Egyptians, cultures were known to have used medicinal plants containing cardiac glycosides. It was not until 1542 that the German scholar Fuchsius coined the now common term digitalis for the foxglove plant. Since 1785, when Sir William Withering published his textbook1 on the "account of the foxglove," physicians have used digitalis preparations to treat edematous states, irregular heartbeats, and chronic heart failure (HF). According to Withering, digitalis was believed to slow heart rate in patients with irregular pulse and result in diuresis.
Mechanism of Action
This article has been cited by other articles:
![]() |
S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, K. Michl, et al. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation J. Am. Coll. Cardiol., April 14, 2009; 53(15): e1 - e90. [Full Text] [PDF] |
||||
![]() |
2005 WRITING COMMITTEE MEMBERS, S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, et al. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation Circulation, April 14, 2009; 119(14): e391 - e479. [Full Text] [PDF] |
||||
![]() |
M. Gheorghiade and P. S. Pang Acute heart failure syndromes. J. Am. Coll. Cardiol., February 17, 2009; 53(7): 557 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Testa, R Bhindi, and A P Banning Digitalis: a dangerous drug in atrial fibrillation? Heart, December 1, 2008; 94(12): 1654 - 1654. [Full Text] [PDF] |
||||
![]() |
A. Thorn, C. Egerer-Sieber, C. M. Jager, V. Herl, F. Muller-Uri, W. Kreis, and Y. A. Muller The Crystal Structure of Progesterone 5{beta}-Reductase from Digitalis lanata Defines a Novel Class of Short Chain Dehydrogenases/Reductases J. Biol. Chem., June 20, 2008; 283(25): 17260 - 17269. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J Simpson Jr Assessing the safety of drugs through observational research Heart, February 1, 2008; 94(2): 129 - 130. [Full Text] [PDF] |
||||
![]() |
A. Ahmed Digoxin and Reduction in Mortality and Hospitalization in Geriatric Heart Failure: Importance of Low Doses and Low Serum Concentrations J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2007; 62(3): 323 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Pierre, C. Yang, Z. Yuan, J. Seminerio, C. Mouas, K. D. Garlid, P. Dos-Santos, and Z. Xie Ouabain triggers preconditioning through activation of the Na+,K+-ATPase signaling cascade in rat hearts Cardiovasc Res, February 1, 2007; 73(3): 488 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Elkareh, D. J. Kennedy, B. Yashaswi, S. Vetteth, A. Shidyak, E. G. R. Kim, S. Smaili, S. M. Periyasamy, I. M. Hariri, L. Fedorova, et al. Marinobufagenin Stimulates Fibroblast Collagen Production and Causes Fibrosis in Experimental Uremic Cardiomyopathy Hypertension, January 1, 2007; 49(1): 215 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ahmed, M. W. Rich, J. L. Fleg, M. R. Zile, J. B. Young, D. W. Kitzman, T. E. Love, W. S. Aronow, K. F. Adams Jr, and M. Gheorghiade Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure: The Ancillary Digitalis Investigation Group Trial Circulation, August 1, 2006; 114(5): 397 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ahmed, I. B. Aban, M. T. Weaver, W. S. Aronow, and J. L. Fleg Serum digoxin concentration and outcomes in women with heart failure: A bi-directional effect and a possible effect modification by ejection fraction Eur J Heart Fail, June 1, 2006; 8(4): 409 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gheorghiade, D. J. van Veldhuisen, and W. S. Colucci Contemporary Use of Digoxin in the Management of Cardiovascular Disorders Circulation, May 30, 2006; 113(21): 2556 - 2564. [Full Text] [PDF] |
||||
![]() |
A. P Benson, R. H Clayton, A. V Holden, S. Kharche, and W. C Tong Endogenous driving and synchronization in cardiac and uterine virtual tissues: bifurcations and local coupling Phil Trans R Soc A, May 15, 2006; 364(1842): 1313 - 1327. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ahmed, M. W. Rich, T. E. Love, D. M. Lloyd-Jones, I. B. Aban, W. S. Colucci, K. F. Adams, and M. Gheorghiade Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial Eur. Heart J., January 2, 2006; 27(2): 178 - 186. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |